None listed
Conditions
Brief summary
In this pilot study, selected pharmacies in the Waitemata District Health Board area will offer Hepatitis C screening for people with risk factors for hepatitis C virus. We will find out the feasibility of doing this. We want to know how many people pharmacy screen, the numbers of positives found, and numbers going on to have positive RNA results, treatment and cure. We will ascertain the risk factors of people being tested, age and ethnicity, and the pharmacists considerations of how feasible this work is. Informed consent will be obtained.
Interventions
Selected community pharmacies will offer screening for hepatitis C virus to people with risk factors for hepatitis C virus. They will then provide lab test forms for anyone with a positive test, and a referral to their general practitioner.
The screening will be a finger prick test taking up to 20 mins for results to come through. It will be administered by pharmacists in a private consulting room with the consumer alone or with their support people if preferred.
No strategies will be used to
Selected community pharmacies will offer screening for hepatitis C virus to people with risk factors for hepatitis C virus. They will then provide lab test forms for anyone with a positive test, and a referral to their general practitioner. The screening will be a finger prick test taking up to 20 mins for results to come through. It will be administered by pharmacists in a private consulting room with the consumer alone or with their support people if preferred. No strategies will be used to monitor adherence, fidelity The researchers at the DHB will follow positive tests on the lab testing and treatment information available to medical practitioners to ascertain outcomes.
Sponsors
Natalie Gauld Ltd
Study design
Allocation
Non-randomised trial
Primary purpose
Diagnosis
Eligibility
Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Pharmacies in the West Auckland area, 5 of which have needle exchange and/or methadone services, 2 of which do not. Pharmacies will be selected purposively to provide good geographical range, some with longer opening hours, and one in a mall if possible. Inclusion criteria for patients, NZ residents who: • ever had a tattoo or body piercing using unsterile equipment • ever injected drugs • had a blood transfusion before 1992 • ever lived or had medical treatment in a high-risk country (e.g. Pakistan, Egypt, developing countries in Africa and Asia, Eastern Europe including Russia) • have ever been in prison • were been born to a mother with hepatitis C, or • are 35 to 69 years old.
Exclusion criteria
Previous positive hepatitis C test
Outcome results
None listed